___

• 1. Fehr AR, Perlman S. Coronaviruses: An overview of their replication and patho-genesis. Methods Mol Biol 2015; 1282: 1–23. 2. Li G, Fan Y, Lai Y et al. Coronavirus infections and immune responses. J Med Virol 2020; 92: 424– 32. 3. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-192. 4. Su S, Wong G, Shi W et al. Epidemiology, genetic recombination, and patho-genesis of coronaviruses. Trends Microbiol 2016; 24: 490-502. 5. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017; 39: 529-539. 6. Drosten C, Günther S, Preiser W et al. Identification of a novel coron- avirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967-1976. 7. Ksiazek TG, Erdman D, Goldsmith CS et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953-1966. 8. WHO. Middle east respiratory syndrome coronavirus (MERS-CoV). 2020. 9. Chan JF-W, Kok K-H, Zhu Z et al. Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020; 9: 221-236. 10. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506. 11. WHO. Novel Coronavirus (COVID-19) Situation. https://experience.arcgis.com/experience /685d0ace521648f8a5beeeee1b9125cd 12. Lu R, Zhao X, Li J et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395: 565-574. 13. Paraskevis D, Kostaki EG, Magiorkinis G et al. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020; 79: 104212. 14. Zhou P, Yang X-L, Wang X-G et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579, 270-273. 15. Li Q, Guan X, Wu P et al. Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia. N Engl J Med 2020; 382: 989- 998. 16. Wang D, Hu B, Hu C et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; E1-E9. doi:10.1001/jama.2020.1585 17. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-513. 18. Zhang H, Kang Z, Gong H et al. The digestive system is a potential route of 2019-nCov infection: A bioinformatics analysis based on single-cell transcriptomes. BioRxiv 2020; 1-19. https://doi. org/10.1101/2020.01.30.927806. 19. Lu C-W, Liu X-F, Jia Z-F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020; 395: e39. 20. Mahase E. China coronavirus: What do we know so far? BMJ 2020; 368: m308. 21. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domes- tic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet 2020; 395: 689-697. 22. Guan WJ, Ni ZY, Hu Y et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 1-13. 23. Michael DC, Susan MP, Mona RL et al. Severe acute respiratory syndrome. Clin Infect Dis 2004; 38: 1407-1420. 24. World Health Organization, Novel Coronavirus (2019-nCoV) Advice for the Public. 2020. 25. Bespoke, Bebot Launches Free Coronavirus Information Bot. 2020. 26. Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. COVID-19 Algoritmalar. https://hsgm.saglik.gov.tr/tr/covid19-algoritmalar 27. Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. COVID-19 (SARSCoV2) Enfeksiyonu Rehberi. Bilim Kurulu Çalışması. https://hsgm.saglik.gov.tr/depo/covid19/ rehberler/COVID-19_RehberiV5-25Subat2020.pdf